319 related articles for article (PubMed ID: 16150644)
1. Chemotherapy of trypanosomiases and leishmaniasis.
Croft SL; Barrett MP; Urbina JA
Trends Parasitol; 2005 Nov; 21(11):508-12. PubMed ID: 16150644
[TBL] [Abstract][Full Text] [Related]
2. Kinetoplastida: new therapeutic strategies.
Croft SL
Parasite; 2008 Sep; 15(3):522-7. PubMed ID: 18814734
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy in the treatment and control of leishmaniasis.
Alvar J; Croft S; Olliaro P
Adv Parasitol; 2006; 61():223-74. PubMed ID: 16735166
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives.
Navarro M; Gabbiani C; Messori L; Gambino D
Drug Discov Today; 2010 Dec; 15(23-24):1070-8. PubMed ID: 20974285
[TBL] [Abstract][Full Text] [Related]
6. Developments in the treatment of leishmaniasis and trypanosomiasis.
Olliaro P; Lazdins J; Guhl F
Expert Opin Emerg Drugs; 2002 May; 7(1):61-7. PubMed ID: 15989536
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy of leishmaniasis and human trypanosomiasis: status and new developments].
Kayser O; Croft SL; Kolodziej H
Pharm Unserer Zeit; 1999 Jul; 28(4):177-85. PubMed ID: 10443145
[No Abstract] [Full Text] [Related]
8. Leishmaniasis: drugs in the clinic, resistance and new developments.
Ouellette M; Drummelsmith J; Papadopoulou B
Drug Resist Updat; 2004; 7(4-5):257-66. PubMed ID: 15533763
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapeutic effectiveness of stibomen in experimental leishmaniasis and trypanosomiasis].
Pershin GN; Moskalenko NIu
Med Parazitol (Mosk); 1967; 36(4):422-7. PubMed ID: 5612807
[No Abstract] [Full Text] [Related]
10. Kahalalide F, an antitumor depsipeptide in clinical trials, and its analogues as effective antileishmanial agents.
Cruz LJ; Luque-Ortega JR; Rivas L; Albericio F
Mol Pharm; 2009; 6(3):813-24. PubMed ID: 19317431
[TBL] [Abstract][Full Text] [Related]
11. [Visceral leishmaniasis: clinical sensitivity and resistance to various therapeutic agents].
Janvier F; Morillon M; Olliaro P
Med Trop (Mars); 2008 Feb; 68(1):89-101. PubMed ID: 18478781
[TBL] [Abstract][Full Text] [Related]
12. Rational approaches for drug designing against leishmaniasis.
Shukla AK; Singh BK; Patra S; Dubey VK
Appl Biochem Biotechnol; 2010 Apr; 160(8):2208-18. PubMed ID: 19756413
[TBL] [Abstract][Full Text] [Related]
13. Novel compounds to combat trypanosomatid infections: a medicinal chemical perspective.
González M; Cerecetto H
Expert Opin Ther Pat; 2011 May; 21(5):699-715. PubMed ID: 21428846
[TBL] [Abstract][Full Text] [Related]
14. New antileishmanial candidates and lead compounds.
Richard JV; Werbovetz KA
Curr Opin Chem Biol; 2010 Aug; 14(4):447-55. PubMed ID: 20400358
[TBL] [Abstract][Full Text] [Related]
15. Complementary medicinal chemistry-driven strategies toward new antitrypanosomal and antileishmanial lead drug candidates.
Cavalli A; Lizzi F; Bongarzone S; Belluti F; Piazzi L; Bolognesi ML
FEMS Immunol Med Microbiol; 2010 Feb; 58(1):51-60. PubMed ID: 19845762
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial peptides for leishmaniasis.
Cobb SL; Denny PW
Curr Opin Investig Drugs; 2010 Aug; 11(8):868-75. PubMed ID: 20721829
[TBL] [Abstract][Full Text] [Related]
17. Management of trypanosomiasis and leishmaniasis.
Barrett MP; Croft SL
Br Med Bull; 2012; 104(1):175-96. PubMed ID: 23137768
[TBL] [Abstract][Full Text] [Related]
18. Protease inhibitors in potential drug development for Leishmaniasis.
Das P; Alam MN; Paik D; Karmakar K; De T; Chakraborti T
Indian J Biochem Biophys; 2013 Oct; 50(5):363-76. PubMed ID: 24772958
[TBL] [Abstract][Full Text] [Related]
19. [Oral miltefosine to treat leishmaniasis].
Soto J; Soto P
Biomedica; 2006 Oct; 26 Suppl 1():207-17. PubMed ID: 17361856
[TBL] [Abstract][Full Text] [Related]
20. Miltefosine: oral treatment of leishmaniasis.
Soto J; Soto P
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):177-85. PubMed ID: 16597200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
